Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-05-06
Original SEC Filing: Click here

---

Webplus: SVA/20200506/6-K/2_EX-99.1/000.htm SEC Original: tm2018799d1_ex99-1.htm
Sinovac Announces First Animal Study Results of Vaccine Against COVID-19 Published in SCIENCE — Inactivated vaccine for SARS-CoV-2 shows good safety and efficacy on Rhesus Macaques BEIJING, China, May 6, 2020 /Business Wire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today the publication of the preclinical study on

---

---

Webplus: SVA/20200506/6-K/1/000.htm SEC Original: tm2018799d1_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-05-06CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200